Gallacher Capital Management’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $336K | Sell |
15,481
-742
| -5% | -$16.1K | 0.16% | 188 |
|
|
2025
Q1 | $393K | Buy |
+16,223
| New | +$393K | 0.19% | 154 |
|
|
2024
Q3 | – | Sell |
-18,564
| Closed | -$288K | – | 288 |
|
|
2024
Q2 | $288K | Buy |
+18,564
| New | +$288K | 0.15% | 189 |
|
|
2024
Q1 | – | Sell |
-14,561
| Closed | -$245K | – | 273 |
|
|
2023
Q4 | $245K | Sell |
14,561
-3,076
| -17% | -$51.7K | 0.14% | 208 |
|
|
2023
Q3 | $206K | Buy |
+17,637
| New | +$206K | 0.13% | 218 |
|